Lumosa Therapeutics Co., Ltd. (6535.TWO)
TWD 144.0
(-10.0%)
TWD 144.0
(-10.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -412.63 Million TWD | 19.43% |
| 2022 | -512.15 Million TWD | 38.21% |
| 2021 | -828.83 Million TWD | 5.99% |
| 2020 | -881.68 Million TWD | -461.26% |
| 2019 | -157.09 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -279.44 Million TWD | -16.87% |
| 2024 Q1 | -239.1 Million TWD | 42.06% |
| 2023 Q4 | -412.63 Million TWD | -16.52% |
| 2023 Q1 | -435.32 Million TWD | 15.0% |
| 2023 FY | -412.63 Million TWD | 19.43% |
| 2023 Q3 | -354.13 Million TWD | -7.55% |
| 2023 Q2 | -329.26 Million TWD | 24.36% |
| 2022 Q3 | -596.68 Million TWD | 0.0% |
| 2022 Q4 | -512.15 Million TWD | 14.17% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | -56.202% |
| Level Biotechnology Inc. | -453.9 Million TWD | 9.091% |
| Sagittarius Life Science Corp | -120.57 Million TWD | -242.239% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | -110.104% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 182.553% |
| GlycoNex Incorporation | -148.56 Million TWD | -177.745% |
| VBI | -25.31 Million TWD | -1529.949% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 1124.78% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 399.024% |
| Visgeneer Inc. | 31.28 Million TWD | 1419.007% |
| Mycenax Biotech Inc. | 207 Million TWD | 299.333% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 39.372% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -207.361% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 166.39% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -615.665% |
| Enimmune corporation | -314.15 Million TWD | -31.347% |
| TaiRx, Inc. | -147.86 Million TWD | -179.056% |
| CHO Pharma, Inc. | -203.79 Million TWD | -102.48% |
| EirGenix Inc. | -4.58 Billion TWD | 91.006% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -386.814% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 441.387% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 87.178% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | -29.998% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -1982.663% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 1397.237% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 913.0% |
| RBC Bioscience Corporation | 422.18 Million TWD | 197.739% |
| BiOptic Inc. | 12.59 Million TWD | 3376.985% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 56.307% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -306.596% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | -149.817% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 231.049% |
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -435.587% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | -57.146% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 1449.46% |
| Neith Corporation | -150.31 Million TWD | -174.523% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -541.529% |
| NaviFUS Corp. | -123.12 Million TWD | -235.127% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 657.235% |
| Sinew Pharma Inc. | -160.34 Million TWD | -157.344% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | -70.587% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | -22.309% |
| AP Biosciences Inc | -196.52 Million TWD | -109.964% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 159.912% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -3507.922% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 50.266% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 130.401% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 0.54% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | -97.116% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | -186.827% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | -24.837% |
| TCI GENE Inc. | -689.25 Million TWD | 40.132% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -246.935% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 68.482% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 2114.539% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -305.063% |
| PharmaEngine, Inc. | -860.8 Million TWD | 52.064% |
| Savior Lifetec Corporation | -812.54 Million TWD | 49.216% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | -37.561% |
| OBI Pharma, Inc. | -398.22 Million TWD | -3.62% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | -12.922% |
| Acepodia, Inc. | -6.02 Billion TWD | 93.146% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 87.87% |